Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells

Cell Host & Microbe
N RieberD Hartl

Abstract

Despite continuous contact with fungi, immunocompetent individuals rarely develop pro-inflammatory antifungal immune responses. The underlying tolerogenic mechanisms are incompletely understood. Using both mouse models and human patients, we show that infection with the human pathogenic fungi Aspergillus fumigatus and Candida albicans induces a distinct subset of neutrophilic myeloid-derived suppressor cells (MDSCs), which functionally suppress T and NK cell responses. Mechanistically, pathogenic fungi induce neutrophilic MDSCs through the pattern recognition receptor Dectin-1 and its downstream adaptor protein CARD9. Fungal MDSC induction is further dependent on pathways downstream of Dectin-1 signaling, notably reactive oxygen species (ROS) generation as well as caspase-8 activity and interleukin-1 (IL-1) production. Additionally, exogenous IL-1β induces MDSCs to comparable levels observed during C. albicans infection. Adoptive transfer and survival experiments show that MDSCs are protective during invasive C. albicans infection, but not A. fumigatus infection. These studies define an innate immune mechanism by which pathogenic fungi regulate host defense.

References

Jun 18, 2005·The Journal of Infectious Diseases·Brad SpellbergScott G Filler
Sep 28, 2007·European Journal of Immunology·Teresa ZelanteLuigina Romani
Dec 15, 2007·Nature Reviews. Microbiology·Mihai G NeteaNeil A R Gow
Jul 9, 2008·Medical Mycology·Luigina RomaniPaolo Puccetti
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Feb 2, 2010·Cell Host & Microbe·Gordon D Brown
Nov 11, 2010·Journal of Innate Immunity·Michail S LionakisPhilip M Murphy
Mar 12, 2011·Nature Reviews. Immunology·Luigina Romani
Jan 19, 2012·Infection and Immunity·Shih-Chin ChengMihai G Netea
Feb 23, 2012·Nature Communications·Teresa ZelanteLuigina Romani
Dec 13, 2012·Annals of the New York Academy of Sciences·Agostinho CarvalhoLuigina Romani
Mar 2, 2013·Current Opinion in Infectious Diseases·Carolina Garcia-VidalJordi Carratalà
Nov 2, 2013·The Journal of Clinical Investigation·Michail S LionakisPhilip M Murphy
May 8, 2014·European Journal of Immunology·Jessica QuintinMihai G Netea

❮ Previous
Next ❯

Citations

Apr 12, 2016·Frontiers in Cellular and Infection Microbiology·Michael OstDominik Hartl
Apr 20, 2016·Frontiers in Cellular and Infection Microbiology·Rebecca A Drummond, Michail S Lionakis
May 15, 2016·Trends in Immunology·Sakeen W Kashem, Daniel H Kaplan
Jun 14, 2016·Nature Reviews. Immunology·Teunis B H Geijtenbeek, Sonja I Gringhuis
Aug 26, 2016·Immunological Reviews·Roel P GazendamTaco W Kuijpers
Oct 30, 2016·Frontiers in Microbiology·Anurag SinghNikolaus Rieber
Oct 26, 2016·JCI Insight·Nikolaus RieberMichail S Lionakis
Mar 28, 2018·Nature Reviews. Immunology·Gordon D BrownLauren Whitehead
Feb 17, 2018·Frontiers in Immunology·Juan TangJian Zhang
Jan 18, 2018·MBio·Elizabeth A LillyMairi C Noverr
Mar 30, 2017·Infection and Immunity·Damien RouxDeborah R Yoder-Himes
Jan 21, 2018·Cell Death & Disease·Xiaoming ZhongZhiwen Yang
Nov 24, 2018·Nature Reviews. Immunology·Jürgen Ruland, Lara Hartjes
Feb 6, 2016·The European Respiratory Journal·Saeed KolahianDominik Hartl
Mar 21, 2019·Allergy·Kazuhiko MaedaShizuo Akira
Oct 11, 2019·Journal of the American Podiatric Medical Association·Aditya K GuptaNeil H Shear
Dec 21, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anna S HeinemannDorothee Viemann
Feb 23, 2017·Frontiers in Immunology·Paulo C RodriguezAmir A Al-Khami
Jul 27, 2017·Molecular Ecology·Monika TrienensBregje Wertheim
Jan 23, 2018·Frontiers in Immunology·Anca Dorhoi, Nelita Du Plessis
May 23, 2018·Cancer Immunology, Immunotherapy : CII·Annika M BrugerSven Brandau
Jan 20, 2018·Nature Immunology·Filippo VegliaDmitry Gabrilovich
Oct 3, 2018·Frontiers in Cellular and Infection Microbiology·Hartmut StollNikolaus Rieber
Aug 8, 2018·International Journal of Molecular Sciences·Andrew J BryantLyle L Moldawer
Mar 16, 2019·Frontiers in Immunology·Irene T SchrijverThierry Roger
Dec 21, 2018·Cancer Immunology, Immunotherapy : CII·Anca DorhoiAnnabel F Valledor
Dec 15, 2016·Frontiers in Cellular and Infection Microbiology·Hasan H ÖzDominik Hartl
Jun 20, 2018·Frontiers in Immunology·Surabhi GoyalHortense Slevogt
Apr 6, 2021·Frontiers in Immunology·Carlos Lamsfus CalleBenjamin Mordmüller
May 14, 2021·Cellular Immunology·Hadas Ashkenazi-PreiserMichal Baniyash
Nov 6, 2018·Immunology Letters·Negar NowroozilarkiSaeed Kolahian
Oct 26, 2016·Microbiology Spectrum·Gordon D Brown, Paul R Crocker
Jul 3, 2021·Journal of Clinical Medicine·Christophe VanhaverAnnika M Bruger
Aug 3, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Balaji PathakumariWeida Liu
Sep 1, 2021·Periodontology 2000·Cristina Cunha Villar, Anna Dongari-Bagtzoglou
Oct 14, 2021·Scientific Reports·Leandro Carvalho Dantas BredaSandro Rogério de Almeida

❮ Previous
Next ❯

Methods Mentioned

BETA
FACS

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.